1. Market Research
  2. > Oncothyreon Inc. - Product Pipeline Review - 2013

Oncothyreon Inc. - Product Pipeline Review - 2013

  • August 2013
  • -
  • Global Markets Direct
  • -
  • 26 pages

Oncothyreon Inc. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Oncothyreon Inc. - Product Pipeline Review - 2013” provides data on the Oncothyreon Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Oncothyreon Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Oncothyreon Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Oncothyreon Inc. - Brief Oncothyreon Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Oncothyreon Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Oncothyreon Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Oncothyreon Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Oncothyreon Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Oncothyreon Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Oncothyreon Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Oncothyreon Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Oncothyreon Inc. and identify potential opportunities in those areas.

Table Of Contents

Oncothyreon Inc. - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Oncothyreon Inc. Snapshot 4
Oncothyreon Inc. Overview 4
Key Information 4
Key Facts 4
Oncothyreon Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Oncothyreon Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Oncothyreon Inc. - Pipeline Products Glance 9
Oncothyreon Inc. Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Oncothyreon Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Oncothyreon Inc. - Drug Profiles 12
ONT-10 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
ONT-701 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
PX-866 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Oncothyreon Inc. - Pipeline Analysis 15
Oncothyreon Inc. - Pipeline Products by Therapeutic Class 15
Oncothyreon Inc. - Pipeline Products By Target 16
Oncothyreon Inc. - Pipeline Products by Route of Administration 17
Oncothyreon Inc. - Pipeline Products By Mechanism of Action 18
Oncothyreon Inc. - Recent Pipeline Updates 19
Oncothyreon Inc. - Dormant Projects 22
Oncothyreon Inc. - Discontinued Pipeline Products 23
Discontinued Pipeline Product Profiles 23
PX-478 23
Theratope 23
Oncothyreon Inc. - Locations And Subsidiaries 24
Head Office 24
Other Locations and Subsidiaries 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26



List of Tables

Oncothyreon Inc., Key Information 4
Oncothyreon Inc., Key Facts 4
Oncothyreon Inc. - Pipeline by Indication, 2013 6
Oncothyreon Inc. - Pipeline by Stage of Development, 2013 7
Oncothyreon Inc. - Monotherapy Products in Pipeline, 2013 8
Oncothyreon Inc. - Phase II, 2013 9
Oncothyreon Inc. - Phase I, 2013 10
Oncothyreon Inc. - Preclinical, 2013 11
Oncothyreon Inc. - Pipeline By Therapeutic Class, 2013 15
Oncothyreon Inc. - Pipeline By Target, 2013 16
Oncothyreon Inc. - Pipeline By Route of Administration, 2013 17
Oncothyreon Inc. - Pipeline Products By Mechanism of Action, 2013 18
Oncothyreon Inc. - Recent Pipeline Updates, 2013 19
Oncothyreon Inc. - Dormant Developmental Projects,2013 22
Oncothyreon Inc. - Discontinued Pipeline Products, 2013 23
Oncothyreon Inc., Subsidiaries 24



List of Figures

Oncothyreon Inc. - Pipeline by Indication, 2013 6
Oncothyreon Inc. - Pipeline by Stage of Development, 2013 7
Oncothyreon Inc. - Monotherapy Products in Pipeline, 2013 8
Oncothyreon Inc. - Pipeline By Therapeutic Class, 2013 15
Oncothyreon Inc. - Pipeline By Route of Administration, 2013 17
Oncothyreon Inc. - Pipeline Products By Mechanism of Action, 2013 18



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.